Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

NCT02307279 is registered in ClinicalTrials.gov with Gelesis, Inc. as lead sponsor.

NCT NCT02307279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02307279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes
Lead sponsor
Gelesis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2014
Completion date
June 30, 2017
Enrollment
436 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight